🔵 Axiolabs Gear

BPC 157

✔️ Substance: BPC 157
✔️ Price For: Vial (5mg)
✔️ Brand: Axiolabs

$24.00 $40.00

Select Shipping Options:

🌐 International (12-15 Days)
🇺🇸 U.S. Domestic (5-7 Days)

International

U.S. Domestic

You will save $16.00

Axiolabs BPC-157 5 mg

IDENTITYCompoundBPC-157 Pentadecapeptide
BrandAxiolabs
Strength5 mg
FormLyophilized Vial
ClassResearch Peptide

PEPTIDE PROFILEStructure15 Amino Acid Peptide
Origin Derived from Gastric Protective Peptide Sequence
CategoryExperimental Healing Peptide
Molecular ActionTissue Repair Signaling
Research StatusPreclinical Studies

PHARMACOLOGY

Administration Subcutaneous (SC) / Research Use

ActivityRegenerative Signaling Pathways

Target AreasSoft Tissue, Tendon, Recovery Research

PCTNot Required

STORAGE & PACKAGEBrandAxiolabs
Package5 mg Multi-dose Vial
Storage Before Reconstitution2-8°C Recommended
ProtectionProtect From Light & Heat
FormFreeze-Dried Powder

DOSING INFORMATIONResearch Range200-500 mcg/day
Common Period2-6 weeks
AdministrationDaily SC Injection
Weekly Amount1.4-3.5 mg/week
5 mg Vial DurationApprox. 10-25 days

USAGE PROFILETypical UseRecovery & Tissue Research
Start TimeEarly Research Period
Duration2-6 Weeks
Administration TimeDaily Schedule
Injection SiteResearch Dependent

ADMINISTRATION PROFILERouteSubcutaneous (SC)
FrequencyOnce Daily Research Protocols
TimingConsistent Daily Timing
Reconstitution Bacteriostatic Water Research Preparation
HandlingAseptic Technique Required

SAFETY PROFILEHuman ApprovalNot FDA Approved Therapy
Toxicity DataLimited Human Data
Hormonal SuppressionNot Expected
Androgenic EffectsNone Known
Monitoring Medical Supervision Recommended

MECHANISM OF ACTIONPathwaysAngiogenesis Signaling
RepairTissue Recovery Research
Blood FlowVascular Signaling Support
Growth FactorsPotential Modulation
InflammationExperimental Regulation

PHARMACOKINETICSPeptide TypeShort Chain Peptide
MetabolismPeptide Breakdown Pathways
Half-lifeNot Fully Established
BioavailabilityRoute Dependent
Research DurationProtocol Dependent

STACKING/COMPATIBILITY

Recovery StackBPC-157 + Physical Therapy Research

Peptide CombinationResearch Combination Dependent

GH RelatedSeparate Mechanism Pathways

Anabolic CompatibilityNo Direct Androgen Interaction

COMPARISONS/ALTERNATIVESBPC-157Recovery Research Profile
TB-500Regenerative Peptide Category
GHGrowth Hormone Pathway
Collagen SupportNutritional Alternative
Research FocusTissue Signaling

WHO IT'S FOR

Athletes researching recovery compounds
Bodybuilding readers interested in peptide science
Individuals studying tissue repair pathways
Researchers examining peptide mechanisms
Sports science audiences

BODYBUILDING USAGE

Recovery support research during intensive training
Used in discussions around tendon and soft tissue research
Not an anabolic compound and does not increase androgen receptor activation
Often researched alongside training recovery strategies
Does not replace nutrition, sleep, or rehabilitation methods

CHEMICAL PROFILECompoundBPC-157 Pentadecapeptide
Peptide Length15 Amino Acids
FormulaC62H98N16O22
CategoryExperimental Peptide
Molecular WeightApprox. 1419.6 g/mol

OVERVIEW

BPC-157 Pentadecapeptide from Axiolabs is an experimental peptide compound studied for its potential role in tissue repair signaling, vascular pathways, and recovery-related biological processes. Unlike anabolic steroids, BPC-157 does not function through androgen receptors and does not directly promote muscle growth through testosterone-related mechanisms.

POTENTIAL BENEFITS

Research interest in tissue recovery pathways
Potential angiogenesis signaling activity
Studied for gastrointestinal protective effects
May influence repair-related biological mechanisms
No direct androgenic or estrogenic activity

POTENTIAL RISKS

Limited long-term human safety data
Not approved as a therapeutic medication
Unknown effects from prolonged non-medical use
Injection-related risks
Possible individual intolerance
Need for quality-controlled pharmaceutical handling

PERFORMANCE PROFILE

Recovery Support

85%

Tissue Research

90%

Muscle Gain

15%

Hormonal Impact

10%

Direct Strength Effect

20%

WHAT IS AXIOLABS?

Axiolabs is a research-focused peptide and biotechnology brand associated with laboratory-oriented compounds. Products marketed under research brands are commonly evaluated by users based on manufacturing standards, documentation, product consistency, and analytical information.

WHY CHOOSE AXIOLABS?

Axiolabs BPC-157 5 mg is positioned as a research peptide product with a focus on formulation consistency and practical vial presentation. Researchers and experienced users typically evaluate peptide products through factors such as compound identity, storage requirements, documentation availability, and manufacturing transparency.

Proper evaluation of any research compound should include consideration of scientific evidence, regulatory status, product quality controls, and responsible handling practices.

CONCLUSION

Axiolabs BPC-157 5 mg contains BPC-157 Pentadecapeptide, an experimental peptide compound investigated in scientific research for its potential involvement in tissue repair signaling, vascular processes, and recovery-related mechanisms.

Unlike anabolic-androgenic steroids, BPC-157 does not directly activate androgen receptors, does not increase testosterone levels, and does not provide traditional anabolic effects such as direct muscle hypertrophy or strength enhancement. Its interest within bodybuilding communities is mainly connected to recovery research, connective tissue studies, and training stress management.

Current scientific knowledge regarding BPC-157 is primarily based on preclinical studies. Human clinical data remain limited, therefore responsible evaluation, appropriate research standards, and awareness of regulatory status are essential when discussing this compound.

DISCLAIMER

This content is provided exclusively for educational and informational purposes. BPC-157 is an experimental peptide and is not approved by major regulatory agencies as a general therapeutic product. This page does not provide medical advice, treatment recommendations, or endorsement of non-approved use. Always consider qualified medical guidance and applicable regulations before using or researching pharmaceutical compounds.